Novartis Ag (NVS) Cash from Investing Activities (2009 - 2025)

Novartis Ag (NVS) has 15 years of Cash from Investing Activities data on file, last reported at -$2.1 billion in Q4 2025.

• Quarterly Cash from Investing Activities rose 48.76% year-over-year to -$2.1 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.9 billion (up 43.2% YoY) and the FY2025 annual result came in at -$4.9 billion, up 35.09% from the prior year.
• Cash from Investing Activities fell to -$2.1 billion in Q4 2025 per NVS's latest filing, from -$860.0 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $9.7 billion in Q4 2023, with the low at -$11.6 billion in Q2 2022.
• Average Cash from Investing Activities over 5 years is -$1.1 billion, with a median of -$899.0 million recorded in 2024.
• Year-over-year, Cash from Investing Activities tumbled 11965.31% in 2022 and surged 530.62% in 2023.
• Novartis Ag's Cash from Investing Activities stood at $883.0 million in 2021, then slumped by 356.29% to -$2.3 billion in 2022, then surged by 530.62% to $9.7 billion in 2023, then plunged by 142.13% to -$4.1 billion in 2024, then jumped by 48.76% to -$2.1 billion in 2025.
• Business Quant data shows NVS's Cash from Investing Activities at -$2.1 billion in Q4 2025, -$860.0 million in Q3 2025, and -$2.2 billion in Q2 2025.